It was Dr Gunson's belief in the 1980s that the risk of infection was 3% for post-transfusion NANBH Read more about It was Dr Gunson's belief in the 1980s that the risk of infection was 3% for post-transfusion NANBH
It was argued during the case that the ALT tests were relatively inexpensive. Mr Underhill QC expressed that cost was not a factor in either ALT testing or anti-HBc testing. Read more about It was argued during the case that the ALT tests were relatively inexpensive. Mr Underhill QC expressed that cost was not a factor in either ALT testing or anti-HBc testing.
Mr Justice Burton expressed the view that if a measure would prevent or reduce risk, it should be taken unless the disadvantages outweigh the advantages. Read more about Mr Justice Burton expressed the view that if a measure would prevent or reduce risk, it should be taken unless the disadvantages outweigh the advantages.
Dr Contreras expressed the view changed for Medicines Control Agency (MCA) from 'maximum benefit at minimal cost' to 'if a measure reduces risk, we should take it' and that she shared this change in view in 1991. Read more about Dr Contreras expressed the view changed for Medicines Control Agency (MCA) from 'maximum benefit at minimal cost' to 'if a measure reduces risk, we should take it' and that she shared this change in view in 1991.
Dr Contreras stated, upon reflection, she had underplayed the risk of NANBH when writing to Dr Barbara in 1987 Read more about Dr Contreras stated, upon reflection, she had underplayed the risk of NANBH when writing to Dr Barbara in 1987
Dr Contreras stated in oral evidence she felt it was taking too long to secure funding for a study into surrogate testing Read more about Dr Contreras stated in oral evidence she felt it was taking too long to secure funding for a study into surrogate testing
Dr Contreras stated in her oral evidence that the pressure to introduce screening was from the liver disease specialists and the Haemophilia Centre Directors Read more about Dr Contreras stated in her oral evidence that the pressure to introduce screening was from the liver disease specialists and the Haemophilia Centre Directors
Dr Contreras wrote to the DHSS saying that a study of anti-HBc in British blood donors should be undertaken. Read more about Dr Contreras wrote to the DHSS saying that a study of anti-HBc in British blood donors should be undertaken.
The Regional Transfusion Directors' meeting agreed that a study on NANB Hepatitis should not be carried out because of lack of time and resources. Read more about The Regional Transfusion Directors' meeting agreed that a study on NANB Hepatitis should not be carried out because of lack of time and resources.
The Statistics Expert Group's Report stated that post-transfusion HCV infections could not be properly estimated before reliable tests were adopted in the early 1990s, and so estimates of the number infected, when based on pre-1990 studies, needed to be treated with great caution. Read more about The Statistics Expert Group's Report stated that post-transfusion HCV infections could not be properly estimated before reliable tests were adopted in the early 1990s, and so estimates of the number infected, when based on pre-1990 studies, needed to be treated with great caution.